The dynamics of cell death patterns and regeneration during acute liver injury in mice
- PMID: 35184410
- PMCID: PMC9063440
- DOI: 10.1002/2211-5463.13383
The dynamics of cell death patterns and regeneration during acute liver injury in mice
Abstract
Acute liver injury is a serious clinical syndrome with multiple causes and unclear pathological process. Here, CCl4 - and D-galactosamine/lipopolysaccharide (D-gal/LPS)-induced acute liver injury was established to explore the cell death patterns and determine whether or not liver regeneration occurred. In CCl4 -induced hepatic injury, three phases, including the early, progressive, and recovery phase, were considered based on alterations of serum transaminases and liver morphology. Moreover, in this model, cytokines exhibited double-peak fluctuations; apoptosis and pyroptosis persisted throughout all phases; autophagy occurred in the early and the progressive phases; and sufficient and timely hepatocyte regeneration was observed only during the recovery phase. All of these phenomena contribute to mild liver injury and subsequent regeneration. Strikingly, only the early and progressive phases were observed in the D-gal/LPS model. Slight pyroptosis occurred in the early phase but diminished in the progressive phase, while apoptosis, reduced autophagy, and slight but subsequently diminished regeneration occurred only during the progressive phase, accompanied by a strong cytokine storm, resulting in severe liver injury with high mortality. Taken together, our work reveals variable modes and dynamics of cell death and regeneration, which lead to different consequences for mild and severe acute liver injury, providing a helpful reference for clinical therapy and prognosis.
Keywords: acute liver injury; cell death; cytokines; hepatocyte; prognosis; regeneration.
© 2022 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.World J Gastroenterol. 2015 Sep 28;21(36):10375-84. doi: 10.3748/wjg.v21.i36.10375. World J Gastroenterol. 2015. PMID: 26420964 Free PMC article.
-
Impaired hepatocyte regeneration in acute severe hepatic injury enhances effective repopulation by transplanted hepatocytes.Cell Transplant. 2009;18(10):1081-92. doi: 10.3727/096368909X12483162196647. Epub 2009 Jun 22. Cell Transplant. 2009. PMID: 19650970
-
Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages.Int Immunopharmacol. 2017 Oct;51:99-106. doi: 10.1016/j.intimp.2017.08.009. Epub 2017 Aug 17. Int Immunopharmacol. 2017. PMID: 28822324
-
Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway.Biomed Pharmacother. 2020 May;125:110020. doi: 10.1016/j.biopha.2020.110020. Epub 2020 Feb 25. Biomed Pharmacother. 2020. PMID: 32106375
-
Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.Biochem Pharmacol. 2022 Jan;195:114863. doi: 10.1016/j.bcp.2021.114863. Epub 2021 Nov 30. Biochem Pharmacol. 2022. PMID: 34861244
Cited by
-
Nanoparticles from grape seed extract inhibit inflammatory cytokines and ameliorate CCl4-induced hepatotoxicity.BMC Complement Med Ther. 2025 Jul 19;25(1):276. doi: 10.1186/s12906-025-05005-7. BMC Complement Med Ther. 2025. PMID: 40684220 Free PMC article.
-
A novel mouse model of hepatocyte-specific apoptosis-induced myeloid cell-dominant sterile liver injury and repair response.Am J Physiol Gastrointest Liver Physiol. 2024 Oct 1;327(4):G499-G512. doi: 10.1152/ajpgi.00005.2024. Epub 2024 Aug 6. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 39104322
-
GPR56 function as a key repressor in hepatocyte pyroptosis and the pathogenesis of liver fibrosis.J Transl Med. 2025 Jun 6;23(1):632. doi: 10.1186/s12967-025-06619-8. J Transl Med. 2025. PMID: 40481471 Free PMC article.
References
-
- Stravitz RT, Lee WM. Acute liver failure. Lancet (London, England). 2019;394:869–81.
-
- Iorga A, Dara L. Cell death in drug‐induced liver injury. Adv Pharmacol (San Diego, Calif). 2019;85:31–74.
-
- Zhao Y, Shi J, Shao F. Inflammatory caspases: activation and cleavage of gasdermin‐D in vitro and during pyroptosis. Methods Mol Biol (Clifton, NJ). 2018;1714:131–48.
-
- Guo H, Xie M, Zhou C, Zheng M. The relevance of pyroptosis in the pathogenesis of liver diseases. Life Sci. 2019;223:69–73. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical